Clinical Trials Browser

Terminated × Recurrence × Imatinib Mesylate × Clear all

NCT00840450 2012-11-19

Imatinib Mesylate (Gleevec) and Paclitaxel in Recurrent Patients of Ovarian and Other Cancers of Mullerian Origin

Phase 2 Terminated

14 enrolled 10 charts

Ovarian Neoplasms, Recurrence